Gene Therapy Helps Advance Cures for Genetic Deafness

The Bertarelli Program in Translational Neuroscience and Neuroengineering has supported researchers from École polytechnique fédérale de Lausanne (EPFL) and Harvard Medical School make great advances in gene therapy to cure genetic deafness.

Now in its second funding round, the Program focuses on supporting collaborative research projects at Harvard Medical School and EPFL bridge the gap between basic and translational neuroscience, support basic and clinical research, by creating stronger ties amongst scientists, engineers and clinicians, and by training the next generation of scientific leaders.

By working with two universities, one with special strength in engineering and technology and the other experienced at alleviating human suffering caused by disease, the Program helps advance cutting edge solutions to challenging medical problems.

By working with two universities, one with special strength in engineering and technology and the other experienced at alleviating human suffering caused by disease, the Program helps advance cutting edge solutions to challenging medical problems.